Tas is the same chemical composition as Ramelteon - a drug that's been approved for sleep problems for ages. Ramelteon sales were decent the first year it was approved; however, it quickly fizzled and now it's dead. Tas is the same #$%$ with a new name, and a new name again. You can't fix non-24 and the market for it is a pure joke. You can get some melatonin supplements and they will do the same job as these "drugs". This whole scam is a joke.
that's called window dressing
and someone sold 200k as well. 1 Hedge dropping it from their portfolio to another Hedge to increase their performance since the stock is up 150%. Learn the market and stop being emotional investors
FDA approvals don't mean anything - look at ROSG and GENE for reference. Obamacare doesn't cover expensive machines. This turd doesn't sell so your arguments are usless. This is going to $2 like it was in July.
YUP! Either $3 to $2, if anyone is willing to pay for garbage
shut the hell up man. Company is no brink of bankruptcy with 4M in the bank. They're talking to bankruptcy specialist. Stop trying to con people so they lose money
at $3 or below.
This is a scam people. I hope no one got caught in this pump and dump.
Revenue for the first six months of 2013 was $18.1 million, down 20.4% compared to $22.8 million in the first six months of 2012.
Gross margins down again YoY. Cancelled orders, interest expense up, revenues down YoY, Cash burn up since they can't sell anything, capital rasiing at $3!! LOL
The net loss was $(7.9) million for the first six months of 2013 versus $(3.0) million for the comparable period in 2012.
And perhaps the biggest dagger, At June 30, 2013, Stereotaxis had cash and cash equivalents of $4.1 million, compared to $9.6 million at March 31, 2013.
Wow!!!! how do you burn through so much cash?!?! Secondary anyone??? LMFAO
Please, tell me? How can people chase stocks that increase 1000% thinking it will go up more? Do people open books and read? I'm flabbergasted. Smart money bought this at $1-$2 range. Downside was minimal.
Open a balance sheet and income statement on this company. There's a good reason why it crashed from $20s to $1. All these companies are in the business to make money - that's why you invest. However, this company has been bleeding red since 2010. All the products, including the most recent FDA approved machine, have been on the market since 2011 in EU and Asia. Bottom line? No one is buying and their YoY revenues have been on a steady decline. No one wants expensive machinery with expert knowledge in this economy. Obamacare won't cover it; hell' we're trying to cut costs and reduce overhead not increase it.
This company can't even maintain 50 million in assets and revenues to stay on Nasdaq - this take effect in September. They only have 8 million left in the bank. That's enough to run through the end of the year. Their debt is over 35 million and increasing. They hired sales force that's not producing anything. More overhead expenses. They have to market this new product in USA which can easily top 20 million. You need a full sales team in states as well, cutting more into their pockets. Yet, they can't make any profit.
Follow the trend. The only reason it went up 1. No short shares available, very small. 2. Small float. You need couple of hundred grand to manipulate this garbage. Thats what a HF did. If you take the real valuation, with the FDA approval, this company is worth about $2-$3. Open a book and stop buying on hype. Read a chart. It was in $1 range all of July. They make 10 million a year and dumb retail is giving them 80 million valuation. On what? Dying technology thats been in use since 2011? This will fluctuate, but it will come back to earth at $3
going from 10 million per year to 100 million? On what valution? These products have been out since 2011, zero sales. Are you nuts? If they get 30-40 million, in 3 years maybe. You guys are nuts
Because it went up 1000% are you people insane? Company is valued at about $2-$3 a share tops. They can go bankrupt by year end. They don't make MONEY.
Garbage stock - All the products have been out since 2011. Why do you think it crashed from $20s to $1? They can't sell anything!! Just like ROSG and GENE. No physician wants to be trained, educated how to operate such expensive machinery when there are simpler methods out there. Obamacare won't cover this either, way too much money. Huge learning curve and it just plain doesn't sell.
I expect this back to $2 in the next 2-4 weeks. Until they show profits, which won't be for a LONG time. They only make 11 million per year. That's a joke. That's not enough to cover their expenses. They will go bankrupt. Their delisting notice is due in September since they can't get to 50 million in assets and revenues.
What a joke!
Adam Feuerstein favorited your Tweets: Can't justify a move when co. is on brink of bankruptcy and delisting. Product can't sell.
Can't wait for him to do an article on this #$%$ co. FDA product has been out since 2011 in Europe and Asia - can't sell worth of poop.